nodes	percent_of_prediction	percent_of_DWPC	metapath
Citalopram—CYP2C19—coronary artery disease	0.167	1	CbGaD
Citalopram—CYP2B6—Clopidogrel—coronary artery disease	0.0248	0.0497	CbGbCtD
Citalopram—ABCB1—Ticagrelor—coronary artery disease	0.0206	0.0412	CbGbCtD
Citalopram—CYP2C19—Gemfibrozil—coronary artery disease	0.0182	0.0364	CbGbCtD
Citalopram—CYP1A2—Gemfibrozil—coronary artery disease	0.0168	0.0336	CbGbCtD
Citalopram—CYP2C19—Clopidogrel—coronary artery disease	0.0158	0.0315	CbGbCtD
Citalopram—CYP2B6—Simvastatin—coronary artery disease	0.0149	0.0297	CbGbCtD
Citalopram—CYP1A2—Clopidogrel—coronary artery disease	0.0145	0.0291	CbGbCtD
Citalopram—CYP2C19—Telmisartan—coronary artery disease	0.0138	0.0276	CbGbCtD
Citalopram—CYP2B6—Atorvastatin—coronary artery disease	0.0132	0.0265	CbGbCtD
Citalopram—ABCB1—Clopidogrel—coronary artery disease	0.0127	0.0255	CbGbCtD
Citalopram—ABCB1—Perindopril—coronary artery disease	0.0127	0.0255	CbGbCtD
Citalopram—CYP3A4—Ticagrelor—coronary artery disease	0.0123	0.0247	CbGbCtD
Citalopram—ABCB1—Telmisartan—coronary artery disease	0.0111	0.0223	CbGbCtD
Citalopram—ABCB1—Pitavastatin—coronary artery disease	0.0111	0.0223	CbGbCtD
Citalopram—CYP2C19—Timolol—coronary artery disease	0.0111	0.0222	CbGbCtD
Citalopram—CYP3A4—Fenofibrate—coronary artery disease	0.011	0.022	CbGbCtD
Citalopram—ABCB1—Lisinopril—coronary artery disease	0.0105	0.0211	CbGbCtD
Citalopram—ABCB1—Enalapril—coronary artery disease	0.0105	0.0211	CbGbCtD
Citalopram—CYP2C19—Rosuvastatin—coronary artery disease	0.0102	0.0203	CbGbCtD
Citalopram—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.00989	0.0198	CbGbCtD
Citalopram—CYP2C19—Simvastatin—coronary artery disease	0.00944	0.0189	CbGbCtD
Citalopram—CYP2C19—Lovastatin—coronary artery disease	0.00924	0.0185	CbGbCtD
Citalopram—CYP2D6—Niacin—coronary artery disease	0.00908	0.0182	CbGbCtD
Citalopram—ABCB1—Timolol—coronary artery disease	0.00896	0.0179	CbGbCtD
Citalopram—CYP3A4—Gemfibrozil—coronary artery disease	0.00878	0.0176	CbGbCtD
Citalopram—CYP2D6—Timolol—coronary artery disease	0.00844	0.0169	CbGbCtD
Citalopram—CYP2C19—Atorvastatin—coronary artery disease	0.00841	0.0168	CbGbCtD
Citalopram—ABCB1—Ezetimibe—coronary artery disease	0.00819	0.0164	CbGbCtD
Citalopram—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00798	0.016	CbGbCtD
Citalopram—ABCB1—Captopril—coronary artery disease	0.00788	0.0158	CbGbCtD
Citalopram—CYP2C19—Losartan—coronary artery disease	0.00769	0.0154	CbGbCtD
Citalopram—CYP3A4—Clopidogrel—coronary artery disease	0.00762	0.0153	CbGbCtD
Citalopram—ABCB1—Simvastatin—coronary artery disease	0.00761	0.0152	CbGbCtD
Citalopram—ABCB1—Pravastatin—coronary artery disease	0.00745	0.0149	CbGbCtD
Citalopram—ABCB1—Lovastatin—coronary artery disease	0.00745	0.0149	CbGbCtD
Citalopram—CYP2D6—Captopril—coronary artery disease	0.00743	0.0149	CbGbCtD
Citalopram—CYP2D6—Simvastatin—coronary artery disease	0.00718	0.0144	CbGbCtD
Citalopram—CYP1A2—Losartan—coronary artery disease	0.0071	0.0142	CbGbCtD
Citalopram—CYP3A4—Eplerenone—coronary artery disease	0.00708	0.0142	CbGbCtD
Citalopram—CYP2D6—Lovastatin—coronary artery disease	0.00702	0.0141	CbGbCtD
Citalopram—CYP2D6—Pravastatin—coronary artery disease	0.00702	0.0141	CbGbCtD
Citalopram—ABCB1—Atorvastatin—coronary artery disease	0.00679	0.0136	CbGbCtD
Citalopram—CYP2D6—Atorvastatin—coronary artery disease	0.0064	0.0128	CbGbCtD
Citalopram—CYP3A4—Enalapril—coronary artery disease	0.00631	0.0126	CbGbCtD
Citalopram—ABCB1—Losartan—coronary artery disease	0.00621	0.0124	CbGbCtD
Citalopram—CYP3A4—Rosuvastatin—coronary artery disease	0.00491	0.00983	CbGbCtD
Citalopram—CYP3A4—Ezetimibe—coronary artery disease	0.00491	0.00983	CbGbCtD
Citalopram—CYP3A4—Simvastatin—coronary artery disease	0.00456	0.00914	CbGbCtD
Citalopram—CYP3A4—Pravastatin—coronary artery disease	0.00446	0.00894	CbGbCtD
Citalopram—CYP3A4—Lovastatin—coronary artery disease	0.00446	0.00894	CbGbCtD
Citalopram—CYP3A4—Atorvastatin—coronary artery disease	0.00407	0.00814	CbGbCtD
Citalopram—CYP3A4—Losartan—coronary artery disease	0.00372	0.00745	CbGbCtD
Citalopram—Escitalopram—CYP2C19—coronary artery disease	0.00138	1	CrCbGaD
Citalopram—Malaise—Lisinopril—coronary artery disease	2.6e-05	0.000109	CcSEcCtD
Citalopram—Anaphylactic shock—Ramipril—coronary artery disease	2.59e-05	0.000109	CcSEcCtD
Citalopram—Oedema—Ramipril—coronary artery disease	2.59e-05	0.000109	CcSEcCtD
Citalopram—Vertigo—Lisinopril—coronary artery disease	2.59e-05	0.000109	CcSEcCtD
Citalopram—Dry mouth—Timolol—coronary artery disease	2.58e-05	0.000109	CcSEcCtD
Citalopram—Pain—Losartan—coronary artery disease	2.58e-05	0.000109	CcSEcCtD
Citalopram—Constipation—Losartan—coronary artery disease	2.58e-05	0.000109	CcSEcCtD
Citalopram—Syncope—Lisinopril—coronary artery disease	2.58e-05	0.000109	CcSEcCtD
Citalopram—Vomiting—Eplerenone—coronary artery disease	2.58e-05	0.000109	CcSEcCtD
Citalopram—Feeling abnormal—Furosemide—coronary artery disease	2.58e-05	0.000109	CcSEcCtD
Citalopram—Leukopenia—Lisinopril—coronary artery disease	2.58e-05	0.000108	CcSEcCtD
Citalopram—Nausea—Fenofibrate—coronary artery disease	2.57e-05	0.000108	CcSEcCtD
Citalopram—Pruritus—Niacin—coronary artery disease	2.57e-05	0.000108	CcSEcCtD
Citalopram—Asthenia—Pravastatin—coronary artery disease	2.57e-05	0.000108	CcSEcCtD
Citalopram—Gastrointestinal pain—Furosemide—coronary artery disease	2.56e-05	0.000108	CcSEcCtD
Citalopram—Rash—Eplerenone—coronary artery disease	2.56e-05	0.000108	CcSEcCtD
Citalopram—Urticaria—Perindopril—coronary artery disease	2.56e-05	0.000108	CcSEcCtD
Citalopram—Hypersensitivity—Trandolapril—coronary artery disease	2.56e-05	0.000108	CcSEcCtD
Citalopram—Dermatitis—Eplerenone—coronary artery disease	2.56e-05	0.000108	CcSEcCtD
Citalopram—Diarrhoea—Valsartan—coronary artery disease	2.56e-05	0.000107	CcSEcCtD
Citalopram—Confusional state—Timolol—coronary artery disease	2.55e-05	0.000107	CcSEcCtD
Citalopram—Shock—Ramipril—coronary artery disease	2.55e-05	0.000107	CcSEcCtD
Citalopram—Hypersensitivity—Enalapril—coronary artery disease	2.55e-05	0.000107	CcSEcCtD
Citalopram—Abdominal pain—Perindopril—coronary artery disease	2.55e-05	0.000107	CcSEcCtD
Citalopram—Body temperature increased—Perindopril—coronary artery disease	2.55e-05	0.000107	CcSEcCtD
Citalopram—Palpitations—Lisinopril—coronary artery disease	2.54e-05	0.000107	CcSEcCtD
Citalopram—Diarrhoea—Olmesartan—coronary artery disease	2.54e-05	0.000107	CcSEcCtD
Citalopram—Headache—Eplerenone—coronary artery disease	2.54e-05	0.000107	CcSEcCtD
Citalopram—Nervous system disorder—Ramipril—coronary artery disease	2.54e-05	0.000107	CcSEcCtD
Citalopram—Thrombocytopenia—Ramipril—coronary artery disease	2.54e-05	0.000107	CcSEcCtD
Citalopram—Anaphylactic shock—Timolol—coronary artery disease	2.53e-05	0.000107	CcSEcCtD
Citalopram—Oedema—Timolol—coronary artery disease	2.53e-05	0.000107	CcSEcCtD
Citalopram—Pruritus—Pravastatin—coronary artery disease	2.53e-05	0.000106	CcSEcCtD
Citalopram—Loss of consciousness—Lisinopril—coronary artery disease	2.53e-05	0.000106	CcSEcCtD
Citalopram—Nausea—Clopidogrel—coronary artery disease	2.53e-05	0.000106	CcSEcCtD
Citalopram—Tachycardia—Ramipril—coronary artery disease	2.53e-05	0.000106	CcSEcCtD
Citalopram—Skin disorder—Ramipril—coronary artery disease	2.52e-05	0.000106	CcSEcCtD
Citalopram—Infection—Timolol—coronary artery disease	2.52e-05	0.000106	CcSEcCtD
Citalopram—Vomiting—Simvastatin—coronary artery disease	2.52e-05	0.000106	CcSEcCtD
Citalopram—Hypersensitivity—Telmisartan—coronary artery disease	2.51e-05	0.000106	CcSEcCtD
Citalopram—Cough—Lisinopril—coronary artery disease	2.51e-05	0.000106	CcSEcCtD
Citalopram—Nausea—Lovastatin—coronary artery disease	2.51e-05	0.000106	CcSEcCtD
Citalopram—Hyperhidrosis—Ramipril—coronary artery disease	2.5e-05	0.000105	CcSEcCtD
Citalopram—Rash—Simvastatin—coronary artery disease	2.49e-05	0.000105	CcSEcCtD
Citalopram—Dermatitis—Simvastatin—coronary artery disease	2.49e-05	0.000105	CcSEcCtD
Citalopram—Asthenia—Trandolapril—coronary artery disease	2.49e-05	0.000105	CcSEcCtD
Citalopram—Shock—Timolol—coronary artery disease	2.49e-05	0.000105	CcSEcCtD
Citalopram—Feeling abnormal—Losartan—coronary artery disease	2.49e-05	0.000105	CcSEcCtD
Citalopram—Urticaria—Furosemide—coronary artery disease	2.49e-05	0.000105	CcSEcCtD
Citalopram—Diarrhoea—Niacin—coronary artery disease	2.49e-05	0.000105	CcSEcCtD
Citalopram—Nervous system disorder—Timolol—coronary artery disease	2.48e-05	0.000104	CcSEcCtD
Citalopram—Asthenia—Enalapril—coronary artery disease	2.48e-05	0.000104	CcSEcCtD
Citalopram—Headache—Simvastatin—coronary artery disease	2.48e-05	0.000104	CcSEcCtD
Citalopram—Abdominal pain—Furosemide—coronary artery disease	2.48e-05	0.000104	CcSEcCtD
Citalopram—Body temperature increased—Furosemide—coronary artery disease	2.48e-05	0.000104	CcSEcCtD
Citalopram—Gastrointestinal pain—Losartan—coronary artery disease	2.47e-05	0.000104	CcSEcCtD
Citalopram—Dizziness—Valsartan—coronary artery disease	2.47e-05	0.000104	CcSEcCtD
Citalopram—Anorexia—Ramipril—coronary artery disease	2.47e-05	0.000104	CcSEcCtD
Citalopram—Nausea—Ezetimibe—coronary artery disease	2.46e-05	0.000104	CcSEcCtD
Citalopram—Skin disorder—Timolol—coronary artery disease	2.46e-05	0.000103	CcSEcCtD
Citalopram—Dizziness—Olmesartan—coronary artery disease	2.46e-05	0.000103	CcSEcCtD
Citalopram—Pruritus—Trandolapril—coronary artery disease	2.46e-05	0.000103	CcSEcCtD
Citalopram—Arthralgia—Lisinopril—coronary artery disease	2.45e-05	0.000103	CcSEcCtD
Citalopram—Chest pain—Lisinopril—coronary artery disease	2.45e-05	0.000103	CcSEcCtD
Citalopram—Myalgia—Lisinopril—coronary artery disease	2.45e-05	0.000103	CcSEcCtD
Citalopram—Hyperhidrosis—Timolol—coronary artery disease	2.45e-05	0.000103	CcSEcCtD
Citalopram—Asthenia—Telmisartan—coronary artery disease	2.45e-05	0.000103	CcSEcCtD
Citalopram—Pruritus—Enalapril—coronary artery disease	2.45e-05	0.000103	CcSEcCtD
Citalopram—Diarrhoea—Pravastatin—coronary artery disease	2.45e-05	0.000103	CcSEcCtD
Citalopram—Anxiety—Lisinopril—coronary artery disease	2.44e-05	0.000103	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	2.43e-05	0.000102	CcSEcCtD
Citalopram—Discomfort—Lisinopril—coronary artery disease	2.42e-05	0.000102	CcSEcCtD
Citalopram—Hypotension—Ramipril—coronary artery disease	2.42e-05	0.000102	CcSEcCtD
Citalopram—Anorexia—Timolol—coronary artery disease	2.41e-05	0.000102	CcSEcCtD
Citalopram—Pruritus—Telmisartan—coronary artery disease	2.41e-05	0.000102	CcSEcCtD
Citalopram—Nausea—Eplerenone—coronary artery disease	2.41e-05	0.000101	CcSEcCtD
Citalopram—Dizziness—Niacin—coronary artery disease	2.4e-05	0.000101	CcSEcCtD
Citalopram—Urticaria—Losartan—coronary artery disease	2.4e-05	0.000101	CcSEcCtD
Citalopram—Dry mouth—Lisinopril—coronary artery disease	2.4e-05	0.000101	CcSEcCtD
Citalopram—Abdominal pain—Losartan—coronary artery disease	2.39e-05	0.0001	CcSEcCtD
Citalopram—Body temperature increased—Losartan—coronary artery disease	2.39e-05	0.0001	CcSEcCtD
Citalopram—Asthenia—Captopril—coronary artery disease	2.38e-05	0.0001	CcSEcCtD
Citalopram—Diarrhoea—Trandolapril—coronary artery disease	2.38e-05	9.99e-05	CcSEcCtD
Citalopram—Vomiting—Valsartan—coronary artery disease	2.38e-05	9.99e-05	CcSEcCtD
Citalopram—Confusional state—Lisinopril—coronary artery disease	2.37e-05	9.96e-05	CcSEcCtD
Citalopram—Diarrhoea—Enalapril—coronary artery disease	2.37e-05	9.95e-05	CcSEcCtD
Citalopram—Hypotension—Timolol—coronary artery disease	2.37e-05	9.95e-05	CcSEcCtD
Citalopram—Dizziness—Pravastatin—coronary artery disease	2.37e-05	9.95e-05	CcSEcCtD
Citalopram—Vomiting—Olmesartan—coronary artery disease	2.36e-05	9.94e-05	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Ramipril—coronary artery disease	2.36e-05	9.93e-05	CcSEcCtD
Citalopram—Rash—Valsartan—coronary artery disease	2.36e-05	9.91e-05	CcSEcCtD
Citalopram—Dermatitis—Valsartan—coronary artery disease	2.35e-05	9.9e-05	CcSEcCtD
Citalopram—Nausea—Simvastatin—coronary artery disease	2.35e-05	9.88e-05	CcSEcCtD
Citalopram—Anaphylactic shock—Lisinopril—coronary artery disease	2.35e-05	9.88e-05	CcSEcCtD
Citalopram—Oedema—Lisinopril—coronary artery disease	2.35e-05	9.88e-05	CcSEcCtD
Citalopram—Pruritus—Captopril—coronary artery disease	2.35e-05	9.87e-05	CcSEcCtD
Citalopram—Rash—Olmesartan—coronary artery disease	2.34e-05	9.86e-05	CcSEcCtD
Citalopram—Insomnia—Ramipril—coronary artery disease	2.34e-05	9.85e-05	CcSEcCtD
Citalopram—Dermatitis—Olmesartan—coronary artery disease	2.34e-05	9.85e-05	CcSEcCtD
Citalopram—Headache—Valsartan—coronary artery disease	2.34e-05	9.84e-05	CcSEcCtD
Citalopram—Diarrhoea—Telmisartan—coronary artery disease	2.33e-05	9.82e-05	CcSEcCtD
Citalopram—Infection—Lisinopril—coronary artery disease	2.33e-05	9.82e-05	CcSEcCtD
Citalopram—Headache—Olmesartan—coronary artery disease	2.33e-05	9.8e-05	CcSEcCtD
Citalopram—Paraesthesia—Ramipril—coronary artery disease	2.33e-05	9.78e-05	CcSEcCtD
Citalopram—Shock—Lisinopril—coronary artery disease	2.31e-05	9.72e-05	CcSEcCtD
Citalopram—Asthenia—Perindopril—coronary artery disease	2.31e-05	9.72e-05	CcSEcCtD
Citalopram—Dyspnoea—Ramipril—coronary artery disease	2.31e-05	9.71e-05	CcSEcCtD
Citalopram—Vomiting—Niacin—coronary artery disease	2.31e-05	9.71e-05	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Timolol—coronary artery disease	2.31e-05	9.7e-05	CcSEcCtD
Citalopram—Hypersensitivity—Furosemide—coronary artery disease	2.31e-05	9.7e-05	CcSEcCtD
Citalopram—Somnolence—Ramipril—coronary artery disease	2.3e-05	9.69e-05	CcSEcCtD
Citalopram—Thrombocytopenia—Lisinopril—coronary artery disease	2.3e-05	9.67e-05	CcSEcCtD
Citalopram—Dizziness—Trandolapril—coronary artery disease	2.3e-05	9.66e-05	CcSEcCtD
Citalopram—Tachycardia—Lisinopril—coronary artery disease	2.29e-05	9.64e-05	CcSEcCtD
Citalopram—Insomnia—Timolol—coronary artery disease	2.29e-05	9.63e-05	CcSEcCtD
Citalopram—Rash—Niacin—coronary artery disease	2.29e-05	9.63e-05	CcSEcCtD
Citalopram—Dermatitis—Niacin—coronary artery disease	2.29e-05	9.62e-05	CcSEcCtD
Citalopram—Dizziness—Enalapril—coronary artery disease	2.29e-05	9.62e-05	CcSEcCtD
Citalopram—Skin disorder—Lisinopril—coronary artery disease	2.28e-05	9.6e-05	CcSEcCtD
Citalopram—Dyspepsia—Ramipril—coronary artery disease	2.28e-05	9.59e-05	CcSEcCtD
Citalopram—Pruritus—Perindopril—coronary artery disease	2.28e-05	9.58e-05	CcSEcCtD
Citalopram—Headache—Niacin—coronary artery disease	2.28e-05	9.57e-05	CcSEcCtD
Citalopram—Paraesthesia—Timolol—coronary artery disease	2.27e-05	9.56e-05	CcSEcCtD
Citalopram—Vomiting—Pravastatin—coronary artery disease	2.27e-05	9.56e-05	CcSEcCtD
Citalopram—Hyperhidrosis—Lisinopril—coronary artery disease	2.27e-05	9.55e-05	CcSEcCtD
Citalopram—Diarrhoea—Captopril—coronary artery disease	2.27e-05	9.55e-05	CcSEcCtD
Citalopram—Dyspnoea—Timolol—coronary artery disease	2.26e-05	9.5e-05	CcSEcCtD
Citalopram—Dizziness—Telmisartan—coronary artery disease	2.26e-05	9.49e-05	CcSEcCtD
Citalopram—Rash—Pravastatin—coronary artery disease	2.26e-05	9.48e-05	CcSEcCtD
Citalopram—Dermatitis—Pravastatin—coronary artery disease	2.25e-05	9.47e-05	CcSEcCtD
Citalopram—Decreased appetite—Ramipril—coronary artery disease	2.25e-05	9.47e-05	CcSEcCtD
Citalopram—Somnolence—Timolol—coronary artery disease	2.25e-05	9.47e-05	CcSEcCtD
Citalopram—Asthenia—Furosemide—coronary artery disease	2.25e-05	9.45e-05	CcSEcCtD
Citalopram—Headache—Pravastatin—coronary artery disease	2.24e-05	9.42e-05	CcSEcCtD
Citalopram—Anorexia—Lisinopril—coronary artery disease	2.24e-05	9.42e-05	CcSEcCtD
Citalopram—Gastrointestinal disorder—Ramipril—coronary artery disease	2.24e-05	9.41e-05	CcSEcCtD
Citalopram—Fatigue—Ramipril—coronary artery disease	2.23e-05	9.39e-05	CcSEcCtD
Citalopram—Dyspepsia—Timolol—coronary artery disease	2.23e-05	9.38e-05	CcSEcCtD
Citalopram—Hypersensitivity—Losartan—coronary artery disease	2.23e-05	9.36e-05	CcSEcCtD
Citalopram—Nausea—Valsartan—coronary artery disease	2.22e-05	9.33e-05	CcSEcCtD
Citalopram—Pruritus—Furosemide—coronary artery disease	2.22e-05	9.32e-05	CcSEcCtD
Citalopram—Constipation—Ramipril—coronary artery disease	2.22e-05	9.32e-05	CcSEcCtD
Citalopram—Nausea—Olmesartan—coronary artery disease	2.21e-05	9.29e-05	CcSEcCtD
Citalopram—Vomiting—Trandolapril—coronary artery disease	2.21e-05	9.29e-05	CcSEcCtD
Citalopram—Diarrhoea—Perindopril—coronary artery disease	2.2e-05	9.27e-05	CcSEcCtD
Citalopram—Decreased appetite—Timolol—coronary artery disease	2.2e-05	9.26e-05	CcSEcCtD
Citalopram—Vomiting—Enalapril—coronary artery disease	2.2e-05	9.25e-05	CcSEcCtD
Citalopram—Hypotension—Lisinopril—coronary artery disease	2.2e-05	9.23e-05	CcSEcCtD
Citalopram—Dizziness—Captopril—coronary artery disease	2.19e-05	9.23e-05	CcSEcCtD
Citalopram—Rash—Trandolapril—coronary artery disease	2.19e-05	9.21e-05	CcSEcCtD
Citalopram—Dermatitis—Trandolapril—coronary artery disease	2.19e-05	9.2e-05	CcSEcCtD
Citalopram—Gastrointestinal disorder—Timolol—coronary artery disease	2.19e-05	9.2e-05	CcSEcCtD
Citalopram—Fatigue—Timolol—coronary artery disease	2.18e-05	9.18e-05	CcSEcCtD
Citalopram—Rash—Enalapril—coronary artery disease	2.18e-05	9.17e-05	CcSEcCtD
Citalopram—Dermatitis—Enalapril—coronary artery disease	2.18e-05	9.16e-05	CcSEcCtD
Citalopram—Headache—Trandolapril—coronary artery disease	2.18e-05	9.15e-05	CcSEcCtD
Citalopram—Vomiting—Telmisartan—coronary artery disease	2.17e-05	9.12e-05	CcSEcCtD
Citalopram—Asthenia—Losartan—coronary artery disease	2.17e-05	9.12e-05	CcSEcCtD
Citalopram—Headache—Enalapril—coronary artery disease	2.17e-05	9.11e-05	CcSEcCtD
Citalopram—Pain—Timolol—coronary artery disease	2.17e-05	9.11e-05	CcSEcCtD
Citalopram—Nausea—Niacin—coronary artery disease	2.16e-05	9.07e-05	CcSEcCtD
Citalopram—Rash—Telmisartan—coronary artery disease	2.15e-05	9.05e-05	CcSEcCtD
Citalopram—Dermatitis—Telmisartan—coronary artery disease	2.15e-05	9.04e-05	CcSEcCtD
Citalopram—Diarrhoea—Furosemide—coronary artery disease	2.14e-05	9.01e-05	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Lisinopril—coronary artery disease	2.14e-05	9e-05	CcSEcCtD
Citalopram—Pruritus—Losartan—coronary artery disease	2.14e-05	8.99e-05	CcSEcCtD
Citalopram—Headache—Telmisartan—coronary artery disease	2.14e-05	8.99e-05	CcSEcCtD
Citalopram—Feeling abnormal—Ramipril—coronary artery disease	2.13e-05	8.98e-05	CcSEcCtD
Citalopram—Dizziness—Perindopril—coronary artery disease	2.13e-05	8.96e-05	CcSEcCtD
Citalopram—Insomnia—Lisinopril—coronary artery disease	2.13e-05	8.94e-05	CcSEcCtD
Citalopram—Nausea—Pravastatin—coronary artery disease	2.12e-05	8.93e-05	CcSEcCtD
Citalopram—Gastrointestinal pain—Ramipril—coronary artery disease	2.12e-05	8.91e-05	CcSEcCtD
Citalopram—Paraesthesia—Lisinopril—coronary artery disease	2.11e-05	8.87e-05	CcSEcCtD
Citalopram—Vomiting—Captopril—coronary artery disease	2.11e-05	8.87e-05	CcSEcCtD
Citalopram—Dyspnoea—Lisinopril—coronary artery disease	2.09e-05	8.81e-05	CcSEcCtD
Citalopram—Rash—Captopril—coronary artery disease	2.09e-05	8.8e-05	CcSEcCtD
Citalopram—Dermatitis—Captopril—coronary artery disease	2.09e-05	8.79e-05	CcSEcCtD
Citalopram—Somnolence—Lisinopril—coronary artery disease	2.09e-05	8.78e-05	CcSEcCtD
Citalopram—Feeling abnormal—Timolol—coronary artery disease	2.09e-05	8.78e-05	CcSEcCtD
Citalopram—Headache—Captopril—coronary artery disease	2.08e-05	8.74e-05	CcSEcCtD
Citalopram—Gastrointestinal pain—Timolol—coronary artery disease	2.07e-05	8.71e-05	CcSEcCtD
Citalopram—Dizziness—Furosemide—coronary artery disease	2.07e-05	8.71e-05	CcSEcCtD
Citalopram—Dyspepsia—Lisinopril—coronary artery disease	2.07e-05	8.7e-05	CcSEcCtD
Citalopram—Diarrhoea—Losartan—coronary artery disease	2.07e-05	8.69e-05	CcSEcCtD
Citalopram—Nausea—Trandolapril—coronary artery disease	2.06e-05	8.68e-05	CcSEcCtD
Citalopram—Urticaria—Ramipril—coronary artery disease	2.06e-05	8.66e-05	CcSEcCtD
Citalopram—Nausea—Enalapril—coronary artery disease	2.05e-05	8.64e-05	CcSEcCtD
Citalopram—Vomiting—Perindopril—coronary artery disease	2.05e-05	8.61e-05	CcSEcCtD
Citalopram—Body temperature increased—Ramipril—coronary artery disease	2.05e-05	8.61e-05	CcSEcCtD
Citalopram—Abdominal pain—Ramipril—coronary artery disease	2.05e-05	8.61e-05	CcSEcCtD
Citalopram—Decreased appetite—Lisinopril—coronary artery disease	2.04e-05	8.59e-05	CcSEcCtD
Citalopram—Rash—Perindopril—coronary artery disease	2.03e-05	8.54e-05	CcSEcCtD
Citalopram—Dermatitis—Perindopril—coronary artery disease	2.03e-05	8.53e-05	CcSEcCtD
Citalopram—Gastrointestinal disorder—Lisinopril—coronary artery disease	2.03e-05	8.53e-05	CcSEcCtD
Citalopram—Nausea—Telmisartan—coronary artery disease	2.03e-05	8.52e-05	CcSEcCtD
Citalopram—Fatigue—Lisinopril—coronary artery disease	2.03e-05	8.52e-05	CcSEcCtD
Citalopram—Headache—Perindopril—coronary artery disease	2.02e-05	8.49e-05	CcSEcCtD
Citalopram—Urticaria—Timolol—coronary artery disease	2.01e-05	8.46e-05	CcSEcCtD
Citalopram—Pain—Lisinopril—coronary artery disease	2.01e-05	8.45e-05	CcSEcCtD
Citalopram—Constipation—Lisinopril—coronary artery disease	2.01e-05	8.45e-05	CcSEcCtD
Citalopram—Abdominal pain—Timolol—coronary artery disease	2e-05	8.42e-05	CcSEcCtD
Citalopram—Body temperature increased—Timolol—coronary artery disease	2e-05	8.42e-05	CcSEcCtD
Citalopram—Dizziness—Losartan—coronary artery disease	2e-05	8.4e-05	CcSEcCtD
Citalopram—Vomiting—Furosemide—coronary artery disease	1.99e-05	8.37e-05	CcSEcCtD
Citalopram—Rash—Furosemide—coronary artery disease	1.97e-05	8.3e-05	CcSEcCtD
Citalopram—Dermatitis—Furosemide—coronary artery disease	1.97e-05	8.3e-05	CcSEcCtD
Citalopram—Nausea—Captopril—coronary artery disease	1.97e-05	8.29e-05	CcSEcCtD
Citalopram—Headache—Furosemide—coronary artery disease	1.96e-05	8.25e-05	CcSEcCtD
Citalopram—Feeling abnormal—Lisinopril—coronary artery disease	1.94e-05	8.14e-05	CcSEcCtD
Citalopram—Gastrointestinal pain—Lisinopril—coronary artery disease	1.92e-05	8.08e-05	CcSEcCtD
Citalopram—Vomiting—Losartan—coronary artery disease	1.92e-05	8.08e-05	CcSEcCtD
Citalopram—Nausea—Perindopril—coronary artery disease	1.91e-05	8.05e-05	CcSEcCtD
Citalopram—Hypersensitivity—Ramipril—coronary artery disease	1.91e-05	8.03e-05	CcSEcCtD
Citalopram—Rash—Losartan—coronary artery disease	1.91e-05	8.01e-05	CcSEcCtD
Citalopram—Dermatitis—Losartan—coronary artery disease	1.9e-05	8e-05	CcSEcCtD
Citalopram—Headache—Losartan—coronary artery disease	1.89e-05	7.96e-05	CcSEcCtD
Citalopram—Urticaria—Lisinopril—coronary artery disease	1.87e-05	7.85e-05	CcSEcCtD
Citalopram—Hypersensitivity—Timolol—coronary artery disease	1.87e-05	7.85e-05	CcSEcCtD
Citalopram—Nausea—Furosemide—coronary artery disease	1.86e-05	7.82e-05	CcSEcCtD
Citalopram—Asthenia—Ramipril—coronary artery disease	1.86e-05	7.82e-05	CcSEcCtD
Citalopram—Abdominal pain—Lisinopril—coronary artery disease	1.86e-05	7.81e-05	CcSEcCtD
Citalopram—Body temperature increased—Lisinopril—coronary artery disease	1.86e-05	7.81e-05	CcSEcCtD
Citalopram—Pruritus—Ramipril—coronary artery disease	1.83e-05	7.71e-05	CcSEcCtD
Citalopram—Asthenia—Timolol—coronary artery disease	1.82e-05	7.64e-05	CcSEcCtD
Citalopram—Nausea—Losartan—coronary artery disease	1.79e-05	7.55e-05	CcSEcCtD
Citalopram—Pruritus—Timolol—coronary artery disease	1.79e-05	7.54e-05	CcSEcCtD
Citalopram—Diarrhoea—Ramipril—coronary artery disease	1.77e-05	7.45e-05	CcSEcCtD
Citalopram—Diarrhoea—Timolol—coronary artery disease	1.73e-05	7.29e-05	CcSEcCtD
Citalopram—Hypersensitivity—Lisinopril—coronary artery disease	1.73e-05	7.28e-05	CcSEcCtD
Citalopram—Dizziness—Ramipril—coronary artery disease	1.71e-05	7.2e-05	CcSEcCtD
Citalopram—Asthenia—Lisinopril—coronary artery disease	1.69e-05	7.09e-05	CcSEcCtD
Citalopram—Dizziness—Timolol—coronary artery disease	1.67e-05	7.04e-05	CcSEcCtD
Citalopram—Pruritus—Lisinopril—coronary artery disease	1.66e-05	6.99e-05	CcSEcCtD
Citalopram—Vomiting—Ramipril—coronary artery disease	1.65e-05	6.93e-05	CcSEcCtD
Citalopram—Rash—Ramipril—coronary artery disease	1.63e-05	6.87e-05	CcSEcCtD
Citalopram—Dermatitis—Ramipril—coronary artery disease	1.63e-05	6.86e-05	CcSEcCtD
Citalopram—Headache—Ramipril—coronary artery disease	1.62e-05	6.83e-05	CcSEcCtD
Citalopram—Vomiting—Timolol—coronary artery disease	1.61e-05	6.77e-05	CcSEcCtD
Citalopram—Diarrhoea—Lisinopril—coronary artery disease	1.61e-05	6.76e-05	CcSEcCtD
Citalopram—Rash—Timolol—coronary artery disease	1.6e-05	6.72e-05	CcSEcCtD
Citalopram—Dermatitis—Timolol—coronary artery disease	1.6e-05	6.71e-05	CcSEcCtD
Citalopram—Headache—Timolol—coronary artery disease	1.59e-05	6.67e-05	CcSEcCtD
Citalopram—Dizziness—Lisinopril—coronary artery disease	1.55e-05	6.53e-05	CcSEcCtD
Citalopram—Nausea—Ramipril—coronary artery disease	1.54e-05	6.47e-05	CcSEcCtD
Citalopram—Nausea—Timolol—coronary artery disease	1.5e-05	6.33e-05	CcSEcCtD
Citalopram—Vomiting—Lisinopril—coronary artery disease	1.49e-05	6.28e-05	CcSEcCtD
Citalopram—Rash—Lisinopril—coronary artery disease	1.48e-05	6.23e-05	CcSEcCtD
Citalopram—Dermatitis—Lisinopril—coronary artery disease	1.48e-05	6.22e-05	CcSEcCtD
Citalopram—Headache—Lisinopril—coronary artery disease	1.47e-05	6.19e-05	CcSEcCtD
Citalopram—Nausea—Lisinopril—coronary artery disease	1.4e-05	5.87e-05	CcSEcCtD
Citalopram—HRH1—Signaling Pathways—F2—coronary artery disease	2.75e-06	2.91e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—FN1—coronary artery disease	2.75e-06	2.91e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—APOB—coronary artery disease	2.75e-06	2.9e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—F2—coronary artery disease	2.74e-06	2.9e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—FN1—coronary artery disease	2.74e-06	2.9e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—GSTP1—coronary artery disease	2.74e-06	2.9e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IL6ST—coronary artery disease	2.74e-06	2.9e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—GSTM1—coronary artery disease	2.74e-06	2.9e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—ESR1—coronary artery disease	2.73e-06	2.89e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IL6ST—coronary artery disease	2.73e-06	2.89e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ALDH2—coronary artery disease	2.72e-06	2.87e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—NFKBIA—coronary artery disease	2.72e-06	2.87e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	2.72e-06	2.87e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—NFKBIA—coronary artery disease	2.71e-06	2.86e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—HMOX1—coronary artery disease	2.7e-06	2.86e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	2.7e-06	2.86e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—FN1—coronary artery disease	2.7e-06	2.85e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—F2—coronary artery disease	2.7e-06	2.85e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IL6ST—coronary artery disease	2.69e-06	2.84e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—LPL—coronary artery disease	2.69e-06	2.84e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—GSTM1—coronary artery disease	2.67e-06	2.83e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—ABCA1—coronary artery disease	2.67e-06	2.82e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—CAT—coronary artery disease	2.67e-06	2.82e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—NFKBIA—coronary artery disease	2.67e-06	2.82e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—HBA1—coronary artery disease	2.65e-06	2.8e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—LIPC—coronary artery disease	2.65e-06	2.8e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CYP2C19—coronary artery disease	2.65e-06	2.8e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	2.65e-06	2.8e-05	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—PIK3CA—coronary artery disease	2.65e-06	2.8e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—SERPINE1—coronary artery disease	2.64e-06	2.79e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—APOC3—coronary artery disease	2.63e-06	2.78e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—KIT—coronary artery disease	2.63e-06	2.78e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—KIT—coronary artery disease	2.62e-06	2.77e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—LPL—coronary artery disease	2.62e-06	2.77e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—GPX1—coronary artery disease	2.62e-06	2.77e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—LDLR—coronary artery disease	2.62e-06	2.77e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PPARG—coronary artery disease	2.6e-06	2.75e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—APOB—coronary artery disease	2.59e-06	2.74e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GSTT1—coronary artery disease	2.59e-06	2.73e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—SLC9A1—coronary artery disease	2.59e-06	2.73e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GOT1—coronary artery disease	2.59e-06	2.73e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GGT1—coronary artery disease	2.59e-06	2.73e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—KIT—coronary artery disease	2.58e-06	2.73e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—POMC—coronary artery disease	2.56e-06	2.71e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—GPX1—coronary artery disease	2.56e-06	2.71e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—FGF2—coronary artery disease	2.56e-06	2.7e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GCLC—coronary artery disease	2.56e-06	2.7e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CETP—coronary artery disease	2.56e-06	2.7e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—CD36—coronary artery disease	2.55e-06	2.7e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PPARG—coronary artery disease	2.54e-06	2.69e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—SDC1—coronary artery disease	2.53e-06	2.67e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—GSK3B—coronary artery disease	2.53e-06	2.67e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PPP2CA—coronary artery disease	2.52e-06	2.67e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—NOS3—coronary artery disease	2.52e-06	2.67e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—GSTM1—coronary artery disease	2.52e-06	2.66e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—GSK3B—coronary artery disease	2.52e-06	2.66e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—POMC—coronary artery disease	2.51e-06	2.65e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—POMC—coronary artery disease	2.51e-06	2.65e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CREB1—coronary artery disease	2.51e-06	2.65e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—POMC—coronary artery disease	2.5e-06	2.64e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CREB1—coronary artery disease	2.5e-06	2.64e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—CD36—coronary artery disease	2.49e-06	2.64e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—GSK3B—coronary artery disease	2.48e-06	2.62e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—LPL—coronary artery disease	2.47e-06	2.61e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PPP2CA—coronary artery disease	2.46e-06	2.6e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—POMC—coronary artery disease	2.46e-06	2.6e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CREB1—coronary artery disease	2.46e-06	2.6e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CCL2—coronary artery disease	2.45e-06	2.59e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—JAK2—coronary artery disease	2.45e-06	2.59e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IL6R—coronary artery disease	2.44e-06	2.58e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CCL2—coronary artery disease	2.44e-06	2.58e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IL6R—coronary artery disease	2.44e-06	2.58e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—MTHFR—coronary artery disease	2.42e-06	2.56e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—GPX1—coronary artery disease	2.41e-06	2.55e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IGF1—coronary artery disease	2.41e-06	2.55e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CCL2—coronary artery disease	2.41e-06	2.54e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IGF1—coronary artery disease	2.4e-06	2.54e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—PIK3CA—coronary artery disease	2.4e-06	2.54e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—MAPK1—coronary artery disease	2.4e-06	2.54e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IL6R—coronary artery disease	2.4e-06	2.54e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—MAPK1—coronary artery disease	2.39e-06	2.53e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PSMB5—coronary artery disease	2.39e-06	2.52e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PSMA6—coronary artery disease	2.39e-06	2.52e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IGF1—coronary artery disease	2.37e-06	2.5e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—MTHFR—coronary artery disease	2.36e-06	2.5e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—MAPK1—coronary artery disease	2.35e-06	2.49e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—CD36—coronary artery disease	2.35e-06	2.48e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—ALB—coronary artery disease	2.34e-06	2.47e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CTGF—coronary artery disease	2.33e-06	2.47e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GSTP1—coronary artery disease	2.32e-06	2.45e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PPP2CA—coronary artery disease	2.32e-06	2.45e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GOT2—coronary artery disease	2.31e-06	2.44e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—HMGCR—coronary artery disease	2.31e-06	2.44e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	2.3e-06	2.43e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—AGT—coronary artery disease	2.3e-06	2.43e-05	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—PIK3CA—coronary artery disease	2.29e-06	2.42e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—HMOX1—coronary artery disease	2.29e-06	2.42e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—SERPINE1—coronary artery disease	2.29e-06	2.42e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—ALB—coronary artery disease	2.29e-06	2.42e-05	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	2.29e-06	2.42e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—SERPINE1—coronary artery disease	2.28e-06	2.41e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—CAT—coronary artery disease	2.26e-06	2.39e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—APOE—coronary artery disease	2.25e-06	2.38e-05	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—PIK3CA—coronary artery disease	2.25e-06	2.38e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—SERPINE1—coronary artery disease	2.25e-06	2.37e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—AGT—coronary artery disease	2.25e-06	2.37e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CXCL8—coronary artery disease	2.24e-06	2.36e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—NOS3—coronary artery disease	2.23e-06	2.36e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—APOA1—coronary artery disease	2.23e-06	2.35e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—MTHFR—coronary artery disease	2.23e-06	2.35e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—FGF2—coronary artery disease	2.22e-06	2.34e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—FGF2—coronary artery disease	2.21e-06	2.33e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—APOE—coronary artery disease	2.2e-06	2.33e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—APOB—coronary artery disease	2.19e-06	2.32e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—NOS3—coronary artery disease	2.19e-06	2.31e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—NOS3—coronary artery disease	2.19e-06	2.31e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—NOS3—coronary artery disease	2.18e-06	2.3e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—FGF2—coronary artery disease	2.17e-06	2.3e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—APOA1—coronary artery disease	2.17e-06	2.3e-05	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—AKT1—coronary artery disease	2.16e-06	2.28e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—NOS3—coronary artery disease	2.14e-06	2.27e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CASP3—coronary artery disease	2.14e-06	2.26e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GSTM1—coronary artery disease	2.13e-06	2.26e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.13e-06	2.25e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—IL6—coronary artery disease	2.13e-06	2.25e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.13e-06	2.25e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—JAK2—coronary artery disease	2.12e-06	2.25e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—JAK2—coronary artery disease	2.12e-06	2.24e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—AGT—coronary artery disease	2.12e-06	2.24e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—LPL—coronary artery disease	2.09e-06	2.21e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—JAK2—coronary artery disease	2.08e-06	2.2e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CCND1—coronary artery disease	2.08e-06	2.2e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—PIK3CA—coronary artery disease	2.08e-06	2.2e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—PIK3CA—coronary artery disease	2.08e-06	2.19e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—APOE—coronary artery disease	2.07e-06	2.19e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ABCA1—coronary artery disease	2.06e-06	2.18e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—APOA1—coronary artery disease	2.05e-06	2.17e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GPX1—coronary artery disease	2.04e-06	2.16e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PTGS2—coronary artery disease	2.04e-06	2.16e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—PIK3CA—coronary artery disease	2.04e-06	2.16e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—MMP9—coronary artery disease	2.02e-06	2.14e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PTGS2—coronary artery disease	2e-06	2.12e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GGT1—coronary artery disease	2e-06	2.11e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GOT1—coronary artery disease	2e-06	2.11e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—CD36—coronary artery disease	1.99e-06	2.1e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PPP2CA—coronary artery disease	1.97e-06	2.08e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PPARG—coronary artery disease	1.96e-06	2.07e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—AKT1—coronary artery disease	1.96e-06	2.07e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CXCL8—coronary artery disease	1.94e-06	2.05e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—POMC—coronary artery disease	1.94e-06	2.05e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CXCL8—coronary artery disease	1.93e-06	2.04e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PPARG—coronary artery disease	1.92e-06	2.03e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CXCL8—coronary artery disease	1.9e-06	2.01e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—POMC—coronary artery disease	1.89e-06	2e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—MTHFR—coronary artery disease	1.89e-06	1.99e-05	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—AKT1—coronary artery disease	1.87e-06	1.98e-05	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—AKT1—coronary artery disease	1.87e-06	1.97e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CASP3—coronary artery disease	1.86e-06	1.96e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CASP3—coronary artery disease	1.85e-06	1.96e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—IL6—coronary artery disease	1.84e-06	1.95e-05	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—AKT1—coronary artery disease	1.84e-06	1.94e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—IL6—coronary artery disease	1.84e-06	1.94e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CASP3—coronary artery disease	1.82e-06	1.92e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—VEGFA—coronary artery disease	1.82e-06	1.92e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—IL6—coronary artery disease	1.81e-06	1.91e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CCND1—coronary artery disease	1.81e-06	1.91e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PPARG—coronary artery disease	1.81e-06	1.91e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CCND1—coronary artery disease	1.8e-06	1.9e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.79e-06	1.89e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—AGT—coronary artery disease	1.79e-06	1.89e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—POMC—coronary artery disease	1.78e-06	1.88e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.78e-06	1.88e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CCND1—coronary artery disease	1.77e-06	1.87e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.77e-06	1.87e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—ALB—coronary artery disease	1.77e-06	1.87e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—APOE—coronary artery disease	1.76e-06	1.86e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—MMP9—coronary artery disease	1.75e-06	1.85e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—MMP9—coronary artery disease	1.75e-06	1.85e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CAT—coronary artery disease	1.74e-06	1.84e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—APOA1—coronary artery disease	1.74e-06	1.83e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—ALB—coronary artery disease	1.72e-06	1.82e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—MMP9—coronary artery disease	1.72e-06	1.82e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—AKT1—coronary artery disease	1.7e-06	1.8e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—AKT1—coronary artery disease	1.7e-06	1.79e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—APOB—coronary artery disease	1.69e-06	1.79e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—NOS3—coronary artery disease	1.69e-06	1.78e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—AKT1—coronary artery disease	1.67e-06	1.76e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—TGFB1—coronary artery disease	1.67e-06	1.76e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.66e-06	1.76e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—NOS3—coronary artery disease	1.65e-06	1.74e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.65e-06	1.74e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—MAPK1—coronary artery disease	1.64e-06	1.73e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—ALB—coronary artery disease	1.62e-06	1.72e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—LPL—coronary artery disease	1.62e-06	1.71e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GPX1—coronary artery disease	1.58e-06	1.67e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—VEGFA—coronary artery disease	1.57e-06	1.66e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—VEGFA—coronary artery disease	1.57e-06	1.66e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—NOS3—coronary artery disease	1.55e-06	1.64e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—VEGFA—coronary artery disease	1.55e-06	1.63e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PTGS2—coronary artery disease	1.54e-06	1.63e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CD36—coronary artery disease	1.54e-06	1.62e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PPARG—coronary artery disease	1.53e-06	1.62e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.52e-06	1.6e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—POMC—coronary artery disease	1.51e-06	1.59e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PTGS2—coronary artery disease	1.51e-06	1.59e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.46e-06	1.54e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—TGFB1—coronary artery disease	1.45e-06	1.53e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—TGFB1—coronary artery disease	1.44e-06	1.52e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.42e-06	1.5e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—PIK3CA—coronary artery disease	1.42e-06	1.5e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—TGFB1—coronary artery disease	1.42e-06	1.5e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—MAPK1—coronary artery disease	1.42e-06	1.5e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—MAPK1—coronary artery disease	1.41e-06	1.49e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—MAPK1—coronary artery disease	1.39e-06	1.47e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—AGT—coronary artery disease	1.38e-06	1.46e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—ALB—coronary artery disease	1.38e-06	1.45e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—APOE—coronary artery disease	1.36e-06	1.43e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—APOA1—coronary artery disease	1.34e-06	1.42e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—NOS3—coronary artery disease	1.32e-06	1.39e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PIK3CA—coronary artery disease	1.26e-06	1.33e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IL6—coronary artery disease	1.26e-06	1.33e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PIK3CA—coronary artery disease	1.23e-06	1.3e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PIK3CA—coronary artery disease	1.23e-06	1.3e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PIK3CA—coronary artery disease	1.23e-06	1.3e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PIK3CA—coronary artery disease	1.21e-06	1.28e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PTGS2—coronary artery disease	1.2e-06	1.27e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PPARG—coronary artery disease	1.18e-06	1.25e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—POMC—coronary artery disease	1.16e-06	1.23e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—AKT1—coronary artery disease	1.16e-06	1.23e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IL6—coronary artery disease	1.09e-06	1.15e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IL6—coronary artery disease	1.09e-06	1.15e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IL6—coronary artery disease	1.07e-06	1.13e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ALB—coronary artery disease	1.06e-06	1.12e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—AKT1—coronary artery disease	1.03e-06	1.09e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—NOS3—coronary artery disease	1.02e-06	1.07e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—AKT1—coronary artery disease	1.01e-06	1.06e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—AKT1—coronary artery disease	1e-06	1.06e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—AKT1—coronary artery disease	1e-06	1.06e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—AKT1—coronary artery disease	9.86e-07	1.04e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PIK3CA—coronary artery disease	9.5e-07	1e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PTGS2—coronary artery disease	9.29e-07	9.82e-06	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PIK3CA—coronary artery disease	9.27e-07	9.8e-06	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PIK3CA—coronary artery disease	8.74e-07	9.24e-06	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—AKT1—coronary artery disease	7.76e-07	8.2e-06	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—AKT1—coronary artery disease	7.58e-07	8.01e-06	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PIK3CA—coronary artery disease	7.4e-07	7.82e-06	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—AKT1—coronary artery disease	7.14e-07	7.55e-06	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—AKT1—coronary artery disease	6.05e-07	6.39e-06	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PIK3CA—coronary artery disease	5.71e-07	6.04e-06	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—AKT1—coronary artery disease	4.67e-07	4.93e-06	CbGpPWpGaD
